The Stack That Swept Every Scoreboard (On Paper)
A new randomized trial in BMC Sports Science, Medicine and Rehabilitation put a simple question to resistance-trained men: does adding collagen to whey beat whey alone, collagen alone, or a placebo? In this study, the whey-plus-collagen stack finished first on every outcome measured. That includes muscle mass, lumbar spine bone mineral density, squat and bench press strength, and bone turnover markers. Before you reorder your supplement stack, you need to know how the study was built.
The Study at a Glance
- Design: double-blind, randomized, placebo-controlled trial
- Sample: 40 resistance-trained men (52 screened), all of whom completed the study
- Groups: whey + collagen (30 g whey + 10 g collagen daily), whey alone (30 g/day), collagen alone (10 g/day), or placebo (10 g/day maltodextrin)
- Training: 8 weeks of supervised resistance training, 3 sessions per week
- Primary outcome: muscle mass by bioelectrical impedance analysis (BIA)
- Secondary outcomes: lumbar spine BMD by DXA, 1RM squat and bench press, and bone turnover markers P1NP (bone formation) and CTX-I (bone resorption)
Exactly Which Outcomes the Stack Won
Muscle mass. The stack gained 2.66 ± 0.25 kg. Whey alone gained 1.59 ± 0.18 kg, collagen alone 0.46 ± 0.13 kg, and placebo 0.10 ± 0.12 kg. Between-group differences were significant (p < 0.001).
Lumbar spine BMD. The stack rose by 0.108 ± 0.027 g/cm². Collagen alone rose by 0.023 ± 0.018 g/cm², and that change was also significant. Whey alone and placebo showed no significant change. Between-group differences were significant (p < 0.001).
Strength. The stack added 15.22 ± 1.04 kg to the squat and 10.63 ± 1.25 kg to the bench press. Whey and collagen alone came next, and placebo barely moved.
Bone turnover. The stack produced marked increases in P1NP and reductions in CTX-I. Collagen alone produced smaller but significant improvements. Whey alone and placebo showed no meaningful changes.
The pattern is that whey drove most of the muscle gain, and collagen was the only single ingredient that moved bone. The stack combined both effects. Whey alone did not budge BMD or bone markers in this trial.
Why the Result Is Plausible
The authors frame whey as the anabolic driver for muscle and collagen as the supplier of connective-tissue and bone-related building blocks. They suggest the two are complementary. That is a reasonable hypothesis, and this trial is consistent with it. It does not prove the mechanism, because the study measured outcomes and not pathways.
The Fine Print: Limitations You Should Weigh
Small sample. Forty men split across four arms leaves very few people per group. Small trials can overstate effects.
Short duration. Eight weeks tells us nothing about whether the gains hold or keep building.
Muscle measured by BIA. Bioelectrical impedance is a convenient estimate, and it is sensitive to hydration status. It is not a gold-standard measure of lean tissue.
A big BMD jump in a short time. A 0.108 g/cm² rise in lumbar spine BMD over 8 weeks is a large change for such a short window. That is my own read, not a point the abstract raises, and it is a good reason to wait for replication before treating it as settled.
Unequal protein totals. The stack delivered 40 g of supplemental protein per day, versus 30 g for whey, 10 g for collagen and none for the maltodextrin placebo. The design therefore cannot cleanly separate a true synergy from a simple "more protein" effect. The abstract does not detail whether total diet was controlled.
Narrow population. All participants were resistance-trained men. The authors themselves call for longer follow-up and more diverse populations. The abstract also does not say which pairwise comparisons were significant, for example the stack versus whey alone on strength. Check the full paper for those.
Practical Takeaways
Dose used in the trial: 30 g/day whey plus 10 g/day collagen, alongside 3 supervised resistance sessions per week. The abstract does not specify timing, such as pre-workout, post-workout or split doses. Any timing advice would go beyond the evidence.
Who it may suit: healthy, resistance-trained men similar to the participants who want to support both muscle and bone while training consistently. The supplement did not replace the training. Every group lifted, and the placebo group gained little.
Who should be cautious or skip it:
- Women, older adults, beginners and people with bone disease, because none of these groups were tested
- Anyone with a dairy allergy or a sensitivity to animal-derived collagen
- People with kidney conditions or other medical issues who have been advised to manage protein intake (general caution, not from this paper); check with a clinician first
- Anyone hoping to treat osteoporosis, because this trial studied healthy lifters and not patients
Bottom Line
This randomized, double-blind trial gives the whey-plus-collagen stack a clean sweep in resistance-trained men over 8 weeks. Collagen alone showed a bone signal, and whey alone showed a muscle signal. The combination showed both. Treat it as a promising lead and not as a final verdict. The small sample, the BIA-based muscle measurement, the unmatched protein totals and the unusually large BMD change all argue for replication before anyone calls this a proven bone-building stack.